Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms
Eplerenone, as compared with placebo, reduced both the risk of death and the risk of hospitalization among patients with systolic heart failure and mild symptoms. (Funded by Pfi...
Publications
1 shownFrequent Co-Authors
Researcher Info
- h-index
- 1
- Publications
- 1
- Citations
- 2,924
- Institution
- Pfizer (United States)
External Links
Identifiers
- ORCID
- 0000-0001-9428-7660
Impact Metrics
h-index
1
h-index: Number of publications with at least h citations each.